Neftaly: Management of Liver Cirrhosis

Liver cirrhosis is a chronic, progressive condition characterized by the replacement of healthy liver tissue with scar tissue, leading to impaired liver function. Effective management requires a multidisciplinary approach aimed at halting disease progression, preventing complications, and improving quality of life.

1. Assessment and Diagnosis

• Clinical Evaluation: Fatigue, jaundice, easy bruising, pruritus, ascites, and hepatic encephalopathy.
• Laboratory Tests: Liver function tests (ALT, AST, ALP, bilirubin), INR, albumin, complete blood count.
• Imaging: Ultrasound, CT, or MRI to assess liver morphology, detect portal hypertension, and screen for hepatocellular carcinoma.
• Liver Biopsy: Considered when diagnosis is uncertain or to assess severity.
• Scoring Systems: Child-Pugh and MELD scores to assess prognosis and guide management.

2. Etiological Treatment

Addressing the underlying cause is critical:

• Chronic Viral Hepatitis: Antiviral therapy for hepatitis B or C.
• Alcoholic Liver Disease: Complete alcohol cessation; consider behavioral therapy or support programs.
• Non-Alcoholic Fatty Liver Disease (NAFLD): Weight loss, glycemic control, and lipid management.
• Autoimmune or Metabolic Disorders: Immunosuppressive therapy or enzyme replacement as indicated.

3. Lifestyle and Supportive Measures

• Nutrition: Adequate protein intake; avoid excessive sodium to reduce fluid retention.
• Vaccinations: Hepatitis A and B, influenza, pneumococcal vaccines.
• Avoid Hepatotoxins: Stop alcohol and unnecessary hepatotoxic medications.
• Physical Activity: Encouraged as tolerated to maintain muscle mass and overall health.

4. Management of Complications

• Ascites: Sodium restriction, diuretics (spironolactone, furosemide); paracentesis for refractory cases.
• Hepatic Encephalopathy: Lactulose, rifaximin, and correction of precipitating factors (infection, GI bleeding, electrolyte disturbances).
• Variceal Bleeding: Endoscopic variceal ligation, non-selective beta-blockers, and acute bleeding management in emergencies.
• Infections: Prompt recognition and treatment; consider prophylactic antibiotics in high-risk patients.
• Hepatocellular Carcinoma Surveillance: Ultrasound ± alpha-fetoprotein every 6 months.

5. Pharmacologic Management

• Symptom-targeted medications include:
  • Diuretics for fluid overload.
  • Beta-blockers for portal hypertension.
  • Vitamin supplementation for deficiencies (e.g., vitamin D, B complex).
  • Pain management: Avoid hepatotoxic drugs; acetaminophen in limited doses is preferred.

6. Advanced Therapies

• Liver Transplantation: Considered for patients with decompensated cirrhosis, poor prognosis (high MELD score), or refractory complications.
• Referral to Specialists: Gastroenterology/hepatology, nutritionists, and transplant teams for comprehensive care.

7. Patient Education

• Recognize early signs of complications (bleeding, confusion, swelling).
• Adherence to medications and follow-up schedules.
• Emphasis on lifestyle modifications and support systems.

8. Monitoring and Follow-Up

• Regular laboratory monitoring for liver function, renal function, and electrolytes.
• Periodic imaging for HCC surveillance and portal hypertension assessment.
• Assessment for transplantation eligibility in progressive cases.

---

Key Takeaway:
Management of liver cirrhosis is multifaceted, combining etiological treatment, complication prevention, lifestyle optimization, and, when necessary, advanced interventions such as liver transplantation. Early recognition, continuous monitoring, and patient engagement are essential to improve outcomes and quality of life.